Serum free light chain assessment in monoclonal gammopathy and kidney disease.
Hutchison CA, Basnayake K, Cockwell P. Nat Rev Nephrol. 2009 Nov;5(11):621-8
This review examines the evidence associated with the use of the free light chain assay.
Related Articles:
- Bedtime Dosing of Antihypertensive Medications Reduces Cardiovascular Risk in CKD
- Stage IV Chronic Kidney Disease
- The importance of residual kidney function for patients on dialysis: a critical review.
Recent Comments